Editas Medicine

Editas Medicine

Senior Director, Bioanalytical and Biomarker Development

Cambridge, Massachusetts, United States · Director

Sponsorship not specified$270k-$300kDetected 89 days ago
FDA RegulatoryCRISPRResearchAnimal StudiesLeadershipCommunicationCollaborationGxPBiostatisticsRegulatory Affairs

About the role

  • Editas Medicine is seeking a strong scientific and strategic leader to join our DMPK, Nonclinical Safety and Translational Sciences (DSTS) group.
  • This highly visible role will be accountable for the preclinical bioanalytical strategy, biomarker strategy, data quality, and regulatory readiness, ensuring successful EDIT-401 IND submission and Clinical Trial execution.
  • The role serves as a critical bridge between DSTS/RTO, Clinical Development, and CMC working closely with Clinical Operations, Regulatory Affairs, and Biostatistics to ensure timelines and regulatory expectations are met.

Responsibilities

  • Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.
  • We invite you to apply and join us at the forefront of innovation and be a key contributor to realizing Editas Medicine's mission of developing transformative medicines for people living with serious diseases.

Requirements

  • To thrive in this role, you will need: PhD or equivalent advanced degree in biochemistry, medicinal chemistry, biology, or related field with 10+ years of relevant industry experience.
  • Experience with LNP and gene therapy is highly desired.

Compensation

  • $270,000 - $300,000 Pay Transparency Editas Medicine is committed to transparency and accuracy in our hiring practices.
  • The anticipated salary range for each position is posted within the role.
  • The final salary offer will be determined based on a comprehensive assessment of the candidate's qualifications, including education, training, and relevant experience.
  • Editas Medicine's compensation philosophy ensures fair and equitable pay practices.

Benefits

  • Additional factors such as external market conditions, the role's criticality, and internal equity will also be considered.

Company info

  • At Editas Medicine, we are pioneering the possible.
  • Our mission and commitment is to translate the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
  • At Editas Medicine, we are a team of passionate problem solvers, harnessing the power and potential of CRISPR gene editing to transform the future of medicine.

This listing is sourced directly from Editas Medicine's careers page and normalized into a canonical job model.